nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—SCN8A—epilepsy syndrome	0.0902	0.225	CbGaD
Tocainide—SCN9A—epilepsy syndrome	0.0729	0.182	CbGaD
Tocainide—SCN3A—epilepsy syndrome	0.0697	0.174	CbGaD
Tocainide—SCN4A—epilepsy syndrome	0.067	0.167	CbGaD
Tocainide—SCN1A—epilepsy syndrome	0.049	0.122	CbGaD
Tocainide—SCN2A—epilepsy syndrome	0.0432	0.108	CbGaD
Tocainide—SCN7A—Rufinamide—epilepsy syndrome	0.0268	0.0557	CbGbCtD
Tocainide—SCN11A—Rufinamide—epilepsy syndrome	0.0213	0.0443	CbGbCtD
Tocainide—SCN8A—Lamotrigine—epilepsy syndrome	0.0202	0.0419	CbGbCtD
Tocainide—SCN8A—Rufinamide—epilepsy syndrome	0.0178	0.037	CbGbCtD
Tocainide—SCN8A—Phenytoin—epilepsy syndrome	0.0156	0.0324	CbGbCtD
Tocainide—SCN11A—Zonisamide—epilepsy syndrome	0.0154	0.0319	CbGbCtD
Tocainide—SCN9A—Lamotrigine—epilepsy syndrome	0.0132	0.0274	CbGbCtD
Tocainide—SCN9A—Lacosamide—epilepsy syndrome	0.0132	0.0274	CbGbCtD
Tocainide—SCN3A—Lamotrigine—epilepsy syndrome	0.0121	0.0251	CbGbCtD
Tocainide—SCN3A—Lacosamide—epilepsy syndrome	0.0121	0.0251	CbGbCtD
Tocainide—SCN9A—Rufinamide—epilepsy syndrome	0.0117	0.0242	CbGbCtD
Tocainide—SCN9A—Carbamazepine—epilepsy syndrome	0.0114	0.0236	CbGbCtD
Tocainide—SCN2A—Lamotrigine—epilepsy syndrome	0.0111	0.0232	CbGbCtD
Tocainide—SCN4A—Lamotrigine—epilepsy syndrome	0.0111	0.0232	CbGbCtD
Tocainide—SCN3A—Rufinamide—epilepsy syndrome	0.0107	0.0222	CbGbCtD
Tocainide—SCN10A—Lacosamide—epilepsy syndrome	0.0104	0.0215	CbGbCtD
Tocainide—SCN10A—Lamotrigine—epilepsy syndrome	0.0104	0.0215	CbGbCtD
Tocainide—SCN1A—Lamotrigine—epilepsy syndrome	0.0104	0.0215	CbGbCtD
Tocainide—SCN9A—Phenytoin—epilepsy syndrome	0.0102	0.0212	CbGbCtD
Tocainide—SCN2A—Rufinamide—epilepsy syndrome	0.00984	0.0205	CbGbCtD
Tocainide—SCN4A—Rufinamide—epilepsy syndrome	0.00984	0.0205	CbGbCtD
Tocainide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.00971	0.0202	CbGbCtD
Tocainide—SCN4A—Carbamazepine—epilepsy syndrome	0.00959	0.0199	CbGbCtD
Tocainide—SCN3A—Phenytoin—epilepsy syndrome	0.00932	0.0194	CbGbCtD
Tocainide—SCN10A—Rufinamide—epilepsy syndrome	0.00915	0.019	CbGbCtD
Tocainide—SCN1A—Rufinamide—epilepsy syndrome	0.00915	0.019	CbGbCtD
Tocainide—SCN4A—Phenytoin—epilepsy syndrome	0.0086	0.0179	CbGbCtD
Tocainide—SCN2A—Phenytoin—epilepsy syndrome	0.0086	0.0179	CbGbCtD
Tocainide—ALB—epilepsy syndrome	0.00853	0.0213	CbGaD
Tocainide—SCN5A—Fosphenytoin—epilepsy syndrome	0.00848	0.0176	CbGbCtD
Tocainide—SCN9A—Zonisamide—epilepsy syndrome	0.0084	0.0175	CbGbCtD
Tocainide—SCN2A—Propofol—epilepsy syndrome	0.00802	0.0167	CbGbCtD
Tocainide—SCN4A—Propofol—epilepsy syndrome	0.00802	0.0167	CbGbCtD
Tocainide—SCN1A—Phenytoin—epilepsy syndrome	0.008	0.0166	CbGbCtD
Tocainide—SCN3A—Zonisamide—epilepsy syndrome	0.00768	0.016	CbGbCtD
Tocainide—SCN4A—Zonisamide—epilepsy syndrome	0.00709	0.0148	CbGbCtD
Tocainide—SCN2A—Zonisamide—epilepsy syndrome	0.00709	0.0148	CbGbCtD
Tocainide—SCN5A—Lamotrigine—epilepsy syndrome	0.00708	0.0147	CbGbCtD
Tocainide—SCN1A—Zonisamide—epilepsy syndrome	0.0066	0.0137	CbGbCtD
Tocainide—SCN5A—Rufinamide—epilepsy syndrome	0.00625	0.013	CbGbCtD
Tocainide—SCN5A—Carbamazepine—epilepsy syndrome	0.0061	0.0127	CbGbCtD
Tocainide—SCN5A—Phenytoin—epilepsy syndrome	0.00547	0.0114	CbGbCtD
Tocainide—SCN1A—Topiramate—epilepsy syndrome	0.00481	0.00999	CbGbCtD
Tocainide—SCN5A—Zonisamide—epilepsy syndrome	0.00451	0.00938	CbGbCtD
Tocainide—SCN3A—spinal nerve—epilepsy syndrome	0.00446	0.135	CbGeAlD
Tocainide—SCN8A—cerebellar cortex—epilepsy syndrome	0.00384	0.116	CbGeAlD
Tocainide—ALB—Oxcarbazepine—epilepsy syndrome	0.00376	0.00782	CbGbCtD
Tocainide—ALB—Fosphenytoin—epilepsy syndrome	0.00329	0.00684	CbGbCtD
Tocainide—SCN5A—Topiramate—epilepsy syndrome	0.00329	0.00683	CbGbCtD
Tocainide—ALB—Clonazepam—epilepsy syndrome	0.00297	0.00618	CbGbCtD
Tocainide—ALB—Rufinamide—epilepsy syndrome	0.00242	0.00504	CbGbCtD
Tocainide—ALB—Phenytoin—epilepsy syndrome	0.00212	0.00441	CbGbCtD
Tocainide—ALB—Propofol—epilepsy syndrome	0.00198	0.00411	CbGbCtD
Tocainide—SCN11A—ganglion—epilepsy syndrome	0.00183	0.0554	CbGeAlD
Tocainide—ALB—Diazepam—epilepsy syndrome	0.00179	0.00372	CbGbCtD
Tocainide—CYP1A2—Carbamazepine—epilepsy syndrome	0.00141	0.00294	CbGbCtD
Tocainide—CYP1A2—Primidone—epilepsy syndrome	0.00132	0.00274	CbGbCtD
Tocainide—CYP1A2—Propofol—epilepsy syndrome	0.00118	0.00246	CbGbCtD
Tocainide—CYP1A2—Phenobarbital—epilepsy syndrome	0.00113	0.00235	CbGbCtD
Tocainide—CYP1A2—Diazepam—epilepsy syndrome	0.00107	0.00223	CbGbCtD
Tocainide—SCN8A—hindbrain—epilepsy syndrome	0.00105	0.0318	CbGeAlD
Tocainide—SCN10A—ganglion—epilepsy syndrome	0.00093	0.0281	CbGeAlD
Tocainide—CYP1A2—Valproic Acid—epilepsy syndrome	0.000844	0.00176	CbGbCtD
Tocainide—SCN1A—hindbrain—epilepsy syndrome	0.000797	0.0241	CbGeAlD
Tocainide—SCN2A—hindbrain—epilepsy syndrome	0.000732	0.0221	CbGeAlD
Tocainide—SCN8A—brainstem—epilepsy syndrome	0.000604	0.0182	CbGeAlD
Tocainide—SCN8A—forebrain—epilepsy syndrome	0.000583	0.0176	CbGeAlD
Tocainide—SCN8A—telencephalon—epilepsy syndrome	0.000536	0.0162	CbGeAlD
Tocainide—SCN11A—spinal cord—epilepsy syndrome	0.000496	0.015	CbGeAlD
Tocainide—SCN1A—brainstem—epilepsy syndrome	0.000457	0.0138	CbGeAlD
Tocainide—SCN1A—forebrain—epilepsy syndrome	0.000441	0.0133	CbGeAlD
Tocainide—SCN11A—head—epilepsy syndrome	0.000441	0.0133	CbGeAlD
Tocainide—SCN2A—brainstem—epilepsy syndrome	0.000419	0.0127	CbGeAlD
Tocainide—SCN11A—nervous system—epilepsy syndrome	0.000418	0.0126	CbGeAlD
Tocainide—SCN1A—telencephalon—epilepsy syndrome	0.000406	0.0122	CbGeAlD
Tocainide—SCN2A—forebrain—epilepsy syndrome	0.000405	0.0122	CbGeAlD
Tocainide—SCN11A—central nervous system—epilepsy syndrome	0.000402	0.0121	CbGeAlD
Tocainide—SCN10A—forebrain—epilepsy syndrome	0.00039	0.0118	CbGeAlD
Tocainide—SCN8A—spinal cord—epilepsy syndrome	0.000376	0.0113	CbGeAlD
Tocainide—SCN7A—head—epilepsy syndrome	0.000375	0.0113	CbGeAlD
Tocainide—SCN2A—telencephalon—epilepsy syndrome	0.000372	0.0112	CbGeAlD
Tocainide—SCN10A—telencephalon—epilepsy syndrome	0.000359	0.0108	CbGeAlD
Tocainide—SCN3A—forebrain—epilepsy syndrome	0.000356	0.0107	CbGeAlD
Tocainide—SCN9A—midbrain—epilepsy syndrome	0.000339	0.0102	CbGeAlD
Tocainide—SCN8A—head—epilepsy syndrome	0.000334	0.0101	CbGeAlD
Tocainide—SCN9A—spinal cord—epilepsy syndrome	0.00033	0.00997	CbGeAlD
Tocainide—SCN3A—telencephalon—epilepsy syndrome	0.000327	0.00987	CbGeAlD
Tocainide—SCN11A—brain—epilepsy syndrome	0.000319	0.00964	CbGeAlD
Tocainide—SCN1A—medulla oblongata—epilepsy syndrome	0.000319	0.00962	CbGeAlD
Tocainide—SCN8A—nervous system—epilepsy syndrome	0.000317	0.00956	CbGeAlD
Tocainide—SCN8A—central nervous system—epilepsy syndrome	0.000305	0.0092	CbGeAlD
Tocainide—Mexiletine—SCN9A—epilepsy syndrome	0.0003	0.0763	CrCbGaD
Tocainide—SCN8A—cerebellum—epilepsy syndrome	0.000298	0.00899	CbGeAlD
Tocainide—SCN2A—medulla oblongata—epilepsy syndrome	0.000292	0.00883	CbGeAlD
Tocainide—SCN1A—midbrain—epilepsy syndrome	0.000291	0.00879	CbGeAlD
Tocainide—SCN1A—spinal cord—epilepsy syndrome	0.000284	0.00858	CbGeAlD
Tocainide—Mexiletine—SCN4A—epilepsy syndrome	0.000275	0.0701	CrCbGaD
Tocainide—SCN7A—brain—epilepsy syndrome	0.000272	0.0082	CbGeAlD
Tocainide—SCN2A—midbrain—epilepsy syndrome	0.000267	0.00807	CbGeAlD
Tocainide—SCN4A—head—epilepsy syndrome	0.000262	0.0079	CbGeAlD
Tocainide—SCN2A—spinal cord—epilepsy syndrome	0.000261	0.00787	CbGeAlD
Tocainide—SCN3A—medulla oblongata—epilepsy syndrome	0.000257	0.00776	CbGeAlD
Tocainide—SCN1A—head—epilepsy syndrome	0.000253	0.00762	CbGeAlD
Tocainide—SCN10A—spinal cord—epilepsy syndrome	0.000251	0.00759	CbGeAlD
Tocainide—SCN4A—nervous system—epilepsy syndrome	0.000248	0.00749	CbGeAlD
Tocainide—Prilocaine—SCN3A—epilepsy syndrome	0.000247	0.0628	CrCbGaD
Tocainide—SCN8A—brain—epilepsy syndrome	0.000242	0.00731	CbGeAlD
Tocainide—SCN1A—nervous system—epilepsy syndrome	0.000239	0.00723	CbGeAlD
Tocainide—SCN4A—central nervous system—epilepsy syndrome	0.000239	0.00721	CbGeAlD
Tocainide—SCN3A—midbrain—epilepsy syndrome	0.000235	0.00709	CbGeAlD
Tocainide—SCN2A—head—epilepsy syndrome	0.000232	0.007	CbGeAlD
Tocainide—SCN1A—central nervous system—epilepsy syndrome	0.000231	0.00696	CbGeAlD
Tocainide—SCN3A—spinal cord—epilepsy syndrome	0.000229	0.00692	CbGeAlD
Tocainide—SCN1A—cerebellum—epilepsy syndrome	0.000225	0.0068	CbGeAlD
Tocainide—SCN10A—head—epilepsy syndrome	0.000223	0.00675	CbGeAlD
Tocainide—Mepivacaine—SCN8A—epilepsy syndrome	0.000221	0.0563	CrCbGaD
Tocainide—SCN2A—nervous system—epilepsy syndrome	0.00022	0.00663	CbGeAlD
Tocainide—SCN9A—brain—epilepsy syndrome	0.000213	0.00642	CbGeAlD
Tocainide—SCN10A—nervous system—epilepsy syndrome	0.000212	0.0064	CbGeAlD
Tocainide—SCN2A—central nervous system—epilepsy syndrome	0.000212	0.00639	CbGeAlD
Tocainide—SCN2A—cerebellum—epilepsy syndrome	0.000207	0.00624	CbGeAlD
Tocainide—SCN10A—central nervous system—epilepsy syndrome	0.000204	0.00616	CbGeAlD
Tocainide—SCN3A—head—epilepsy syndrome	0.000204	0.00615	CbGeAlD
Tocainide—SCN5A—head—epilepsy syndrome	0.000203	0.00613	CbGeAlD
Tocainide—Levobupivacaine—SCN4A—epilepsy syndrome	0.000201	0.0513	CrCbGaD
Tocainide—SCN3A—nervous system—epilepsy syndrome	0.000193	0.00583	CbGeAlD
Tocainide—SCN5A—nervous system—epilepsy syndrome	0.000193	0.00581	CbGeAlD
Tocainide—SCN4A—brain—epilepsy syndrome	0.00019	0.00573	CbGeAlD
Tocainide—SCN3A—central nervous system—epilepsy syndrome	0.000186	0.00561	CbGeAlD
Tocainide—SCN5A—central nervous system—epilepsy syndrome	0.000185	0.0056	CbGeAlD
Tocainide—SCN1A—brain—epilepsy syndrome	0.000183	0.00552	CbGeAlD
Tocainide—SCN3A—cerebellum—epilepsy syndrome	0.000182	0.00549	CbGeAlD
Tocainide—Mepivacaine—SCN9A—epilepsy syndrome	0.000179	0.0455	CrCbGaD
Tocainide—Mexiletine—SCN2A—epilepsy syndrome	0.000177	0.0452	CrCbGaD
Tocainide—Ropivacaine—SCN8A—epilepsy syndrome	0.000175	0.0445	CrCbGaD
Tocainide—Prilocaine—SCN1A—epilepsy syndrome	0.000173	0.0441	CrCbGaD
Tocainide—Mepivacaine—SCN3A—epilepsy syndrome	0.000171	0.0436	CrCbGaD
Tocainide—SCN2A—brain—epilepsy syndrome	0.000168	0.00507	CbGeAlD
Tocainide—Mepivacaine—SCN4A—epilepsy syndrome	0.000164	0.0419	CrCbGaD
Tocainide—SCN10A—brain—epilepsy syndrome	0.000162	0.00489	CbGeAlD
Tocainide—Bupivacaine—SCN4A—epilepsy syndrome	0.000161	0.041	CrCbGaD
Tocainide—Prilocaine—SCN2A—epilepsy syndrome	0.000153	0.0389	CrCbGaD
Tocainide—SCN3A—brain—epilepsy syndrome	0.000148	0.00446	CbGeAlD
Tocainide—SCN5A—brain—epilepsy syndrome	0.000147	0.00444	CbGeAlD
Tocainide—Ropivacaine—SCN9A—epilepsy syndrome	0.000141	0.036	CrCbGaD
Tocainide—Ropivacaine—SCN3A—epilepsy syndrome	0.000135	0.0344	CrCbGaD
Tocainide—Ropivacaine—SCN4A—epilepsy syndrome	0.00013	0.0331	CrCbGaD
Tocainide—Mepivacaine—SCN1A—epilepsy syndrome	0.00012	0.0306	CrCbGaD
Tocainide—ALB—brain—epilepsy syndrome	0.000118	0.00356	CbGeAlD
Tocainide—Mepivacaine—SCN2A—epilepsy syndrome	0.000106	0.027	CrCbGaD
Tocainide—Lidocaine—SCN9A—epilepsy syndrome	0.000103	0.0262	CrCbGaD
Tocainide—Lidocaine—SCN3A—epilepsy syndrome	9.82e-05	0.025	CrCbGaD
Tocainide—Ropivacaine—SCN1A—epilepsy syndrome	9.49e-05	0.0242	CrCbGaD
Tocainide—Lidocaine—SCN4A—epilepsy syndrome	9.43e-05	0.024	CrCbGaD
Tocainide—Ropivacaine—SCN2A—epilepsy syndrome	8.37e-05	0.0213	CrCbGaD
Tocainide—Lidocaine—SCN2A—epilepsy syndrome	6.08e-05	0.0155	CrCbGaD
Tocainide—Mexiletine—CYP2D6—epilepsy syndrome	4.68e-05	0.0119	CrCbGaD
Tocainide—Bupivacaine—CYP2C19—epilepsy syndrome	3.7e-05	0.00942	CrCbGaD
Tocainide—Bupivacaine—CYP2D6—epilepsy syndrome	2.74e-05	0.00698	CrCbGaD
Tocainide—Ropivacaine—CYP2D6—epilepsy syndrome	2.21e-05	0.00563	CrCbGaD
Tocainide—Lidocaine—CYP2D6—epilepsy syndrome	1.61e-05	0.00409	CrCbGaD
Tocainide—Lidocaine—ABCB1—epilepsy syndrome	1.15e-05	0.00292	CrCbGaD
Tocainide—SCN4A—Developmental Biology—RELA—epilepsy syndrome	5.22e-06	6.39e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	5.22e-06	6.39e-05	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	5.15e-06	6.32e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—FLNA—epilepsy syndrome	5.05e-06	6.19e-05	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—TNF—epilepsy syndrome	5.03e-06	6.17e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—RELA—epilepsy syndrome	5.03e-06	6.17e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—RELA—epilepsy syndrome	5.03e-06	6.17e-05	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	5.01e-06	6.14e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	5e-06	6.13e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	5e-06	6.13e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	5e-06	6.13e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	5e-06	6.13e-05	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.98e-06	6.1e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—KDR—epilepsy syndrome	4.91e-06	6.02e-05	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	4.9e-06	6e-05	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	4.9e-06	6e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.85e-06	5.95e-05	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MMP9—epilepsy syndrome	4.84e-06	5.93e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	4.81e-06	5.89e-05	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	4.79e-06	5.88e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—KCNMA1—epilepsy syndrome	4.79e-06	5.87e-05	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	4.77e-06	5.85e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.74e-06	5.8e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SLC8A1—epilepsy syndrome	4.73e-06	5.8e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6ST—epilepsy syndrome	4.71e-06	5.77e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.67e-06	5.73e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.65e-06	5.7e-05	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MMP9—epilepsy syndrome	4.63e-06	5.67e-05	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—TNF—epilepsy syndrome	4.6e-06	5.64e-05	CbGpPWpGaD
Tocainide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	4.51e-06	5.53e-05	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—SRC—epilepsy syndrome	4.46e-06	5.47e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GLUD1—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PDXK—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADK—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—L2HGDH—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CERS1—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—FAR1—epilepsy syndrome	4.46e-06	5.46e-05	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MMP9—epilepsy syndrome	4.45e-06	5.45e-05	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MMP9—epilepsy syndrome	4.45e-06	5.45e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.44e-06	5.44e-05	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	4.38e-06	5.37e-05	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TNF—epilepsy syndrome	4.38e-06	5.37e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.37e-06	5.36e-05	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—VEGFA—epilepsy syndrome	4.35e-06	5.33e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MMP9—epilepsy syndrome	4.29e-06	5.26e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MMP9—epilepsy syndrome	4.29e-06	5.26e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	4.28e-06	5.24e-05	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—SRC—epilepsy syndrome	4.27e-06	5.23e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.25e-06	5.21e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.24e-06	5.2e-05	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MMP9—epilepsy syndrome	4.22e-06	5.18e-05	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—AKT1—epilepsy syndrome	4.21e-06	5.15e-05	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	4.17e-06	5.11e-05	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—VEGFA—epilepsy syndrome	4.16e-06	5.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CA13—epilepsy syndrome	4.12e-06	5.04e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	4.11e-06	5.04e-05	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—SRC—epilepsy syndrome	4.1e-06	5.02e-05	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—SRC—epilepsy syndrome	4.1e-06	5.02e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.09e-06	5.02e-05	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	4.09e-06	5.01e-05	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	4.09e-06	5.01e-05	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	4.09e-06	5.01e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PNPO—epilepsy syndrome	4.08e-06	5e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NHLRC1—epilepsy syndrome	4.08e-06	5e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—EPM2A—epilepsy syndrome	4.08e-06	5e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GAMT—epilepsy syndrome	4.08e-06	5e-05	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—VEGFA—epilepsy syndrome	3.99e-06	4.89e-05	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—VEGFA—epilepsy syndrome	3.99e-06	4.89e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PPIA—epilepsy syndrome	3.97e-06	4.87e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—SRC—epilepsy syndrome	3.95e-06	4.85e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—SRC—epilepsy syndrome	3.95e-06	4.85e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.95e-06	4.84e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.95e-06	4.84e-05	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—SRC—epilepsy syndrome	3.89e-06	4.77e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—VEGFA—epilepsy syndrome	3.85e-06	4.72e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—VEGFA—epilepsy syndrome	3.85e-06	4.72e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—FGF2—epilepsy syndrome	3.81e-06	4.67e-05	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—VEGFA—epilepsy syndrome	3.79e-06	4.65e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CA4—epilepsy syndrome	3.79e-06	4.65e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—QDPR—epilepsy syndrome	3.79e-06	4.65e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.79e-06	4.64e-05	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—AKT1—epilepsy syndrome	3.75e-06	4.59e-05	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TNF—epilepsy syndrome	3.72e-06	4.56e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ATP2A2—epilepsy syndrome	3.63e-06	4.45e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—COX3—epilepsy syndrome	3.56e-06	4.37e-05	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TNF—epilepsy syndrome	3.56e-06	4.37e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—RELA—epilepsy syndrome	3.54e-06	4.33e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.52e-06	4.32e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ITGA2—epilepsy syndrome	3.52e-06	4.31e-05	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	3.48e-06	4.26e-05	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—AKT1—epilepsy syndrome	3.43e-06	4.2e-05	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TNF—epilepsy syndrome	3.42e-06	4.19e-05	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TNF—epilepsy syndrome	3.42e-06	4.19e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	3.39e-06	4.16e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CACNA2D2—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PFKL—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC6A8—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLCO1A2—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—KCNB1—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.31e-06	4.06e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.3e-06	4.05e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TNF—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TNF—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.28e-06	4.02e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.22e-06	3.95e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.14e-06	3.85e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PDXK—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—FAR1—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CERS1—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADK—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	3.12e-06	3.82e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ADRA2A—epilepsy syndrome	3.1e-06	3.8e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NEU1—epilepsy syndrome	3.09e-06	3.79e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—UPB1—epilepsy syndrome	3.09e-06	3.79e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ATIC—epilepsy syndrome	3.09e-06	3.79e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PLAT—epilepsy syndrome	3.08e-06	3.78e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MMP9—epilepsy syndrome	3.01e-06	3.69e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD17B4—epilepsy syndrome	2.97e-06	3.65e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS1—epilepsy syndrome	2.9e-06	3.55e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPP1R3C—epilepsy syndrome	2.87e-06	3.52e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GBE1—epilepsy syndrome	2.87e-06	3.52e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GAMT—epilepsy syndrome	2.85e-06	3.5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	2.85e-06	3.5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PNPO—epilepsy syndrome	2.85e-06	3.5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	2.85e-06	3.5e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.81e-06	3.44e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—SRC—epilepsy syndrome	2.78e-06	3.41e-05	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—AKT1—epilepsy syndrome	2.77e-06	3.4e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT3—epilepsy syndrome	2.72e-06	3.33e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—epilepsy syndrome	2.71e-06	3.32e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ASAH1—epilepsy syndrome	2.7e-06	3.31e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PLAUR—epilepsy syndrome	2.68e-06	3.29e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.67e-06	3.27e-05	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—AKT1—epilepsy syndrome	2.65e-06	3.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—QDPR—epilepsy syndrome	2.65e-06	3.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CA4—epilepsy syndrome	2.65e-06	3.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	2.64e-06	3.24e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—STXBP1—epilepsy syndrome	2.63e-06	3.22e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NT5E—epilepsy syndrome	2.56e-06	3.14e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ALAD—epilepsy syndrome	2.56e-06	3.14e-05	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—AKT1—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—AKT1—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—COX3—epilepsy syndrome	2.49e-06	3.06e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—CDC42—epilepsy syndrome	2.48e-06	3.04e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—AKT1—epilepsy syndrome	2.46e-06	3.01e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—AKT1—epilepsy syndrome	2.46e-06	3.01e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CACNA1A—epilepsy syndrome	2.44e-06	2.99e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ALDH7A1—epilepsy syndrome	2.44e-06	2.99e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ST3GAL3—epilepsy syndrome	2.39e-06	2.93e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	2.36e-06	2.9e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	2.36e-06	2.9e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PFKL—epilepsy syndrome	2.36e-06	2.9e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	2.36e-06	2.9e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	2.36e-06	2.9e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADSL—epilepsy syndrome	2.34e-06	2.87e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TNF—epilepsy syndrome	2.32e-06	2.84e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.31e-06	2.83e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GLUL—epilepsy syndrome	2.3e-06	2.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.3e-06	2.81e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CACNA1D—epilepsy syndrome	2.25e-06	2.76e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—FYN—epilepsy syndrome	2.21e-06	2.7e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ATIC—epilepsy syndrome	2.16e-06	2.65e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—UPB1—epilepsy syndrome	2.16e-06	2.65e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NEU1—epilepsy syndrome	2.16e-06	2.65e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—YWHAZ—epilepsy syndrome	2.12e-06	2.6e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—TXNRD1—epilepsy syndrome	2.11e-06	2.58e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.1e-06	2.57e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	2.08e-06	2.55e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.08e-06	2.55e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—AQP1—epilepsy syndrome	2.05e-06	2.51e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.01e-06	2.46e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	2.01e-06	2.46e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GBE1—epilepsy syndrome	2.01e-06	2.46e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.99e-06	2.45e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.97e-06	2.41e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.96e-06	2.41e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.94e-06	2.38e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.89e-06	2.32e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PLAU—epilepsy syndrome	1.88e-06	2.31e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CHRM3—epilepsy syndrome	1.85e-06	2.27e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.85e-06	2.27e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.84e-06	2.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.79e-06	2.2e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.79e-06	2.2e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.75e-06	2.14e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS2—epilepsy syndrome	1.73e-06	2.12e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT1—epilepsy syndrome	1.73e-06	2.12e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.72e-06	2.11e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.71e-06	2.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.71e-06	2.09e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.69e-06	2.07e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.67e-06	2.05e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.64e-06	2.01e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.61e-06	1.97e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.58e-06	1.93e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ABCG2—epilepsy syndrome	1.51e-06	1.85e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.48e-06	1.81e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.47e-06	1.8e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.46e-06	1.79e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.45e-06	1.78e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.43e-06	1.76e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.38e-06	1.69e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.32e-06	1.62e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.3e-06	1.59e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.3e-06	1.59e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.26e-06	1.54e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—BCHE—epilepsy syndrome	1.25e-06	1.53e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.24e-06	1.52e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.21e-06	1.48e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.19e-06	1.46e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.18e-06	1.45e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PLCB1—epilepsy syndrome	1.18e-06	1.45e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—TH—epilepsy syndrome	1.18e-06	1.44e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.16e-06	1.42e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.06e-06	1.29e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.03e-06	1.26e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SRC—epilepsy syndrome	1.03e-06	1.26e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.02e-06	1.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.02e-06	1.24e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—epilepsy syndrome	1e-06	1.23e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HMOX1—epilepsy syndrome	9.81e-07	1.2e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CAT—epilepsy syndrome	9.68e-07	1.19e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ABCB1—epilepsy syndrome	9.42e-07	1.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.25e-07	1.13e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	9.23e-07	1.13e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	8.78e-07	1.08e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GPX1—epilepsy syndrome	8.76e-07	1.07e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—BCHE—epilepsy syndrome	8.75e-07	1.07e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	8.34e-07	1.02e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	8.25e-07	1.01e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TH—epilepsy syndrome	8.22e-07	1.01e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.1e-07	9.92e-06	CbGpPWpGaD
Tocainide—ALB—Metabolism—AGT—epilepsy syndrome	7.68e-07	9.41e-06	CbGpPWpGaD
Tocainide—ALB—Metabolism—APOE—epilepsy syndrome	7.52e-07	9.22e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	6.86e-07	8.41e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CAT—epilepsy syndrome	6.77e-07	8.3e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	6.59e-07	8.08e-06	CbGpPWpGaD
Tocainide—ALB—Metabolism—POMC—epilepsy syndrome	6.46e-07	7.92e-06	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT1—epilepsy syndrome	6.39e-07	7.83e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	6.13e-07	7.51e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.37e-07	6.58e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—APOE—epilepsy syndrome	5.26e-07	6.45e-06	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—epilepsy syndrome	5.16e-07	6.32e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.52e-07	5.54e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.12e-07	5.05e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.61e-07	4.42e-06	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKT1—epilepsy syndrome	2.59e-07	3.18e-06	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.81e-07	2.22e-06	CbGpPWpGaD
